Italy Biomaterials in Healthcare Market Report 2022 to 2030

Italy Biomaterials in Healthcare Market Analysis

$ 3999

The Italy Biomaterials Healthcare Market is expected to witness growth from $3.75 Bn in 2022 to $9.75 Bn in 2030 with a CAGR of 12.70% for the forecasted year 2022-2030. The prevalence of persistent illnesses like diabetes, cancer, and cardiovascular disease is increasing in Italy. which fuels the demand for biomaterials in the healthcare sector in Italy. As a consequence, the biomaterials healthcare market in Italy is growing. The market is segmented by type and by application. Some key players in this market include Finceramica Faenza, Lima Corporate, Serbios, BASF SE, Celanese, and Evonik Industries.

ID: IN10ITMD003 CATEGORY: Medical Devices GEOGRAPHY: Italy AUTHOR: Jigyasu Bhandari

Buy Now

Italy Biomaterials in Healthcare Market Executive Analysis

The Italy Biomaterials Healthcare Market size is at around $3.75 Bn in 2022 and is projected to reach $9.75 Bn in 2030, exhibiting a CAGR of 12.70% during the forecast period. In Italy, the average annual cost of healthcare is $2,906, and the annual cost of healthcare as a proportion of GDP is 8.67%. Italy's health expenses in 2020 were roughly 74% publicly funded, which is a lower proportion than the EU average of 80%. The Italian government allocated an additional $3.85 billion in 2020 and $1.9 billion in 2021 for the health system, an increase of 3.3% and 1.7% over the initial funding plan.

In Italy, the field of medicine known as regenerative medicine successfully employs tissue engineering techniques and stem cell therapy to promote the repair or replacement of damaged tissues or organs. The biomaterial that directs biological processes to re-establish tissue continuity is unquestionably a key component. The versatility of polymers, whether they are natural or synthetic, allows for a broad range of applications. In reality, they can be applied as base materials, coatings, or carriers to functionalize a variety of biomaterials. Italy has a large number of internationally renowned facilities for the study and creation of biomaterials. Every novel biomaterial strives to have several benefits, such as minimal antigenicity and fibrogenic, the absence of local or systemic toxicity, infectious safety, hemocompatibility, a minimal infection-promoting effect, the capacity to serve as a substrate for cell adhesion and proliferation, the ability to allow the deposition of the extracellular matrix (ECM), controlled degradability, mechanical resilience, ductility to processing, ease of sterilisation, and economic convenience.

Italy Biomaterials Healthcare Market Analysis

Market Dynamics

Market Growth Drivers

In Italy, the incidence of persistent illnesses like diabetes, cancer, and cardiovascular disease is rising. The creation of novel therapies for these conditions, including implantable tissue-engineered devices and drug delivery systems, can make use of biomaterials. The demand for medical devices and treatments that deal with age-related conditions is being driven by Italy's big and ageing populace. Orthopaedic implants, dressings for wound healing, and cardiovascular devices are just a few of the medical therapies and devices that can be created using biomaterials. Patients in Italy are looking for novel treatments and devices that use biomaterials as they become more aware of their advantages. Manufacturers are working to meet patient requirements, which is driving growth in the biomaterials market. Innovation in the field is being stimulated by developments in biomaterials technology, including novel materials and production methods. The Italian biomaterial healthcare market is anticipated to grow as a result of these developments, which are producing new and better biomaterials products.

Market Restraints

In Italy, to guarantee the safety and effectiveness of their biomaterials, manufacturers in Italy are subject to stringent regulations governing the biomaterial healthcare sector. Manufacturers may face major difficulties as a result of regulatory procedures that may be time-consuming and expensive. Due to the intricate procedures and materials required, making biomaterials in Italy may be expensive. Due to this, manufacturers may find it challenging to contend with less expensive options. Manufacturers in the Italy Biomaterials Healthcare market may face supply chain difficulties because some biomaterials demand for particular base materials that may be hard to come by.

Competitive Landscape

Key Players

Finceramica faenza (IT)
Lima Corporate (IT)
Serbios (IT)
BASF SE
Celanese
Covestro AG

Notable Recent Deals

2021: A partnership between the US-based Aesculap Implant Systems and the Italian biomaterials firm Finceramica Faenza was announced in 2021. The combined effort will be concentrated on the creation and marketing of novel orthopaedic biomaterials for joint regeneration and repair.

Healthcare Policies and Regulatory Landscape

The Italian Medicines Agency (AIFA) and the Ministry of Health are in charge of overseeing the regulatory framework and healthcare policies for biomaterials in the Italian healthcare industry. Medical Device Regulation (MDR) governs the sale of medical equipment in Italy, including biomaterials. It outlines the standards for medical device efficacy and safety as well as the duties of producers, importers, and distributors. To guarantee that biomaterials are produced consistently and uphold the necessary quality standards, Italian regulatory authorities implement Good Manufacturing Practice (GMP) standards. The Italian National Healthcare System (SSN) offers reimbursement for medical devices that are on its inventory of eligible items, which includes biomaterials. The Ministry of Health regularly updates the roster.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Biomaterials in Healthcare Market Segmentation

By Type (Revenue, USD Billion):

Based on type, the market is segmented into Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, and Natural Biomaterials. The Metallic Biomaterials segment accounted for the largest share of the Itlay market in 2019. The growing geriatric population Itlayly is expected to drive growth for this segment.

Metallic Biomaterials
- Stainless Steel
- Titanium & Titanium Alloys
- Cobalt-Chrome Alloys
- Gold
- Silver
- Magnesium
Polymeric Biomaterials
- Polymethylmethacrylate
- Polyethylene
- Polyester
- Silicone Rubber
- Nylon
- Polyetheretherketone
- Other Polymeric Biomaterials
Ceramics
- Calcium Phosphate
- Zirconia
- Aluminum Oxide
- Calcium Sulfate
- Carbon
- Glass
Natural Biomaterials
- Hyaluronic Acid
- Collagen
- Gelatin
- Fibrin
- Cellulose
- Chitin
- Alginates
- Silk

By Application (Revenue, USD Billion):

The cardiovascular, orthopaedic, dental, plastic surgery, wound healing, tissue engineering, ophthalmology, neurological/CNS, and other applications segments are made up of the biomaterials market. The market category for wound healing is anticipated to have the highest CAGR in 2019. The market will increase as a result of factors including expanding healthcare infrastructure, a large population pool, a rising diabetic population, and rising healthcare spending. Surgical Guides

Cardiovascular
- Catheters
- Stents
- Implantable Cardiac Defibrillators
- Pacemakers
- Sensors
- Heart Valves
- Vascular Grafts
- Guidewires
- Others
Orthopedic
- Joint Replacement
  - Knee Replacement
  - Hip Replacement
  - Shoulder Replacement
  - Others
- Viscosupplementation
- Bioresorbable Tissue Fixation
- Spine?
  - Spinal Fusion Surgeries
  - Minimally Invasive Fusion Surgeries
  - Motion Preservation & Dynamic Stabilization Surgeries
    - Pedicle-Based Rod Systems
    - Interspinous Spacers
    - Artificial Discs
- Fracture Fixation Devices
  - Bone Plates
  - Screws
  - Pins
  - Rods
  - Wires
- Synthetics Bone Grafts
Ophthalmology
- Contact Lenses
  - Intraocular Lenses
  - Functional Replacement of Ocular Tissues
  - Synthetic Corneas
  - Others
Dental
- Dental Implants
- Dental Bone Grafts & Substitutes
- Dental Membranes
- Tissue Regeneration
Plastic Surgery
- Soft-Tissue Fillers
- Craniofacial Surgery
Wound Healing
- Wound Closure Devices
  - Sutures
  - Staples
- Surgical Hemostats
- Internal Tissue Sealants
- Adhesion Barriers
- Hernia Meshes
Tissue Engineering
- Scaffolds for Regenerative Medicine
- Nanomaterials for Biosensing
- Tailoring of Inorganic Nanoparticles
  ?
Neurological/Central Nervous System Applications
- Shunting Systems
- Cortical Neural Prosthetics
- Hydrogel Scaffolds for CNS Repair
- Neural Stem Cell Encapsulation
  ?
Other Applications
- Drug Delivery Systems
- Gastrointestinal Applications
- Bariatric Surgery
- Urinary Applications

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.